On December 30, Gelonghui reported that Jiangsu Nhwa Pharmaceutical (002262.SZ) announced that the Board of Directors recently received a resignation letter from independent director Academician Wang Guangji, who, due to the need to comply with the regulations for part-time management stipulated in the 'Management Measures for Academicians of the Chinese Academy of Engineering,' applied to resign from his positions as independent director and member of the Board of Directors' Global Strategy Committee. After his resignation, Academician Wang Guangji will no longer hold any position in the company.